Apricoxib

DB12378InvestigationalSmall molecule

Apricoxib has been used in trials studying the treatment and prevention of Lung Cancer, Breast Cancer, Pancreatic Cancer, Non Small Cell Lung Cancer, and Metastatic Pancreatic Cancer, among others.

Mechanism: Pharmacologically active on Prostaglandin G/H synthase 2
Curator reviewed
Formula / weight: C₁₉H₂₀N₂O₃S · 356.44 g/mol (avg)

Resolves to

Compound

UNII5X5HB3VZ3ZCAS197904-84-0ChEMBLCHEMBL1835207PubChem9820073

Structure

InChIKeyJTMITOKKUMVWRT-UHFFFAOYSA-NSMILESCCOC1=CC=C(C=C1)C1=CC(C)=CN1C1=CC=C(C=C1)S(N)(=O)=O

Targets

P35354PTGS2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Apricoxib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account